Literature DB >> 12169675

Rapid detection of IgH/BCL2 rearrangement in follicular lymphoma by interphase fluorescence in situ hybridization with bacterial artificial chromosome probes.

Feng Jiang1, Fan Lin, Roger Price, Jun Gu, L Jeffrey Medeiros, Hua Z Zhang, Su-Su Xie, Nancy P Caraway, Ruth L Katz.   

Abstract

Follicular lymphomas (FLs) can be difficult to diagnose on aspirated specimens since the architectural pattern is not present. FLs characteristically have rearrangements in the IgH and BCL2 genes resulting from the reciprocal t(14;18) (q32; q21) translocation. Because of the dispersed distribution of breakpoints, fluorescence in situ hybridization (FISH) using genomic probes that span or flank the breakpoints is ideal for detecting this rearrangement in fine-needle aspiration (FNA) biopsies. To develop a set of probes, a bacterial artificial chromosome library was screened and the clones were mapped by fiber FISH. The probes were produced by the direct incorporation of fluorochrome-labeled nucleotides. The colocalization base FISH assay was applied to Cytospin preparations from FNA biopsies of lymph nodes from 26 patients with FL and 10 patients without FL. In those with FL, the percentage of cells with at least one IgH/BCL2 fusion signal ranged from 22% to 100% (mean, 63%), which was statistically significantly higher than that in FL-negative samples (mean, 2.7%). The probes demonstrated a significantly lower cutoff value (7%) in normal controls and effectively reduced the false-positive rate in FL-negative cases. These results were confirmed with fiber FISH assays on the same specimens. This interphase FISH assay is rapid and reliable for detecting rearrangements in the IGH/BCL2 gene, thereby aiding in the diagnosis of FL on FNA biopsy specimens.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12169675      PMCID: PMC1906983          DOI: 10.1016/S1525-1578(10)60695-2

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  29 in total

1.  V(D)J recombinase-mediated transposition of the BCL2 gene to the IGH locus in follicular lymphoma.

Authors:  J W Vaandrager; E Schuuring; K Philippo; P M Kluin
Journal:  Blood       Date:  2000-09-01       Impact factor: 22.113

2.  Characterisation of BCL2-JH rearrangements in follicular lymphoma: PCR detection of 3' BCL2 breakpoints and evidence of a new cluster.

Authors:  G Buchonnet; P Lenain; P Ruminy; S Lepretre; A Stamatoullas; F Parmentier; F Jardin; C Duval; H Tilly; C Bastard
Journal:  Leukemia       Date:  2000-09       Impact factor: 11.528

3.  A DNA probe combination for improved detection of MLL/11q23 breakpoints by double-color interphase-FISH in acute leukemias.

Authors:  A von Bergh; B Emanuel; S van Zelderen-Bhola; T Smetsers; R van Soest; M Stul; H Vranckx; E Schuuring; A Hagemeijer; P Kluin
Journal:  Genes Chromosomes Cancer       Date:  2000-05       Impact factor: 5.006

Review 4.  The development and applications of the bacterial artificial chromosome cloning system.

Authors:  H Shizuya; H Kouros-Mehr
Journal:  Keio J Med       Date:  2001-03

5.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

Authors:  D Hockenbery; G Nuñez; C Milliman; R D Schreiber; S J Korsmeyer
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

6.  Interphase FISH detection of BCL2 rearrangement in follicular lymphoma using breakpoint-flanking probes.

Authors:  J W Vaandrager; E Schuuring; T Raap; K Philippo; K Kleiverda; P Kluin
Journal:  Genes Chromosomes Cancer       Date:  2000-01       Impact factor: 5.006

7.  Detection of chromosome 11q13 breakpoints by interphase fluorescence in situ hybridization. A useful ancillary method for the diagnosis of mantle cell lymphoma.

Authors:  R L Katz; N P Caraway; J Gu; F Jiang; L A Pasco-Miller; A B Glassman; R Luthra; K J Hayes; J E Romaguera; F F Cabanillas; L J Medeiros
Journal:  Am J Clin Pathol       Date:  2000-08       Impact factor: 2.493

8.  Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32).

Authors:  J W Janssen; J W Vaandrager; T Heuser; A Jauch; P M Kluin; E Geelen; P L Bergsagel; W M Kuehl; H G Drexler; T Otsuki; C R Bartram; E Schuuring
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

9.  Use of novel t(11;14) and t(14;18) dual-fusion fluorescence in situ hybridization probes in the differential diagnosis of lymphomas of small lymphocytes.

Authors:  J L Frater; E K Tsiftsakis; E D Hsi; J Pettay; R R Tubbs
Journal:  Diagn Mol Pathol       Date:  2001-12

10.  Multiple recurrent genomic defects in follicular lymphoma. A possible model for cancer.

Authors:  J J Yunis; G Frizzera; M M Oken; J McKenna; A Theologides; M Arnesen
Journal:  N Engl J Med       Date:  1987-01-08       Impact factor: 91.245

View more
  4 in total

1.  Retinoblastoma protein is frequently absent or phosphorylated in anaplastic large-cell lymphoma.

Authors:  George Z Rassidakis; Raymond Lai; Marco Herling; Candy Cromwell; Annette Schmitt-Graeff; L Jeffrey Medeiros
Journal:  Am J Pathol       Date:  2004-06       Impact factor: 4.307

2.  Genomic profiles in stage I primary non small cell lung cancer using comparative genomic hybridization analysis of cDNA microarrays.

Authors:  Feng Jiang; Zhengnan Yin; Nancy P Caraway; Ruiyun Li; Ruth L Katz
Journal:  Neoplasia       Date:  2004 Sep-Oct       Impact factor: 5.715

3.  The complex translocation (9;14;14) involving IGH and CEBPE genes suggests a new subgroup in B-lineage acute lymphoblastic leukemia.

Authors:  Rachid Zerrouki; Traki Benhassine; Mustapha Bensaada; Patricia Lauzon; Anissa Trabzi
Journal:  Genet Mol Biol       Date:  2016-03       Impact factor: 1.771

4.  CD10 down expression in follicular lymphoma correlates with gastrointestinal lesion involving the stomach and large intestine.

Authors:  Nobuhiko Ohnishi; Katsuyoshi Takata; Tomoko Miyata-Takata; Yasuharu Sato; Akira Tari; Yuka Gion; Mai Noujima-Harada; Kohei Taniguchi; Tetsuya Tabata; Keina Nagakita; Shizuma Omote; Hiroyuki Takahata; Masaya Iwamuro; Hiroyuki Okada; Yoshinobu Maeda; Hiroyuki Yanai; Tadashi Yoshino
Journal:  Cancer Sci       Date:  2016-10-14       Impact factor: 6.716

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.